Doxorubicin
Tracked across 1 events · 8 articles · First seen Sep 13, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Researchers at the National University of Singapore (NUS) have demonstrated a non-invasive approach for targeted breast cancer therapy using pulsed electromagnetic fields (PEMFs). The study, led by Associate Professor Alfredo Franco-Obregon from the NUS Yong…
Impact: Doxorubicin is a chemotherapy drug whose uptake is enhanced by PEMF exposure, potentially allowing lower dosages and reduced side effects. The research may affect demand for doxorubicin if PEMF therapy reduces required chemotherapy doses.
Sep 13, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Doxorubicin live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard